The $3.5 million gift creates endowed chairs at Sarver Heart Center and the Eller College of Management.

Researchers are developing a mobile assessment tool to more accurately, and in near real-time, track and measure saturated fat and added sugar consumption.

Ginny L. Clements’ 65th anniversary as a breast cancer survivor and the future of breast cancer research and patient care will be discussed at the event.

As a mother and a scientist, Veilia Leybas Nuño, PhD, was eager to study a family-focused intervention for children with ADHD.

Experts from the College of Medicine – Tucson are working to counteract fears surrounding the COVID-19 vaccine.

Even after just one dose of the mRNA vaccines made by Pfizer and Moderna, the vaccines reduced the chance of getting infected with SARS-CoV-2, researchers report March 29 in Morbidity and Mortality Weekly Report. “We clearly showed in our study that if you were at least 14 days out from your first shot, you had 80% protection" from infection, said Jeff Burgess, associate dean for research at the Mel and Enid Zuckerman College of Public Health at the University of Arizona.

Data from ongoing University of Arizona Health Sciences research have confirmed the findings from Phase III clinical trials conducted by Pfizer and Moderna for COVID-19 vaccine approval. The findings, published by the CDC, are the first in the U.S. to measure vaccine effectiveness against both symptomatic and asymptomatic COVID-19 specifically among first responders, health care and frontline workers.

Dr. Shad Marvasti, associate professor with the University of Arizona College of Medicine in Phoenix discusses the current state of COVID-19 in Arizona.

Arizona residents, including underserved and underrepresented populations, will have better access to cutting-edge cancer therapies.

AZ HEROES study data show a 90% effective rate after the recommended two doses of Pfizer and Moderna COVID-19 vaccines, confirming trial studies.